Trend
DailyUptrend (confirmed)
4 hourExpanding
1 hourBearish
15 minLeaning Bearish
5 minStrong Bearish
Daily trend turns down below $21.40
Key levels
Resistance$28.38
Resistance$27.09
Support$25.71
Support$23.62
Latest news & SEC filings
AnalystBarclays keeps Underweight rating on Baxter International, lifts target to $23
GuidanceBaxter International revises its 2026 outlook and cuts debt
AnalystJP Morgan keeps Neutral rating on Baxter International, cuts price target to $25
All BAX news →Baxter International makes medical products used in acute and chronic care, including intravenous fluids, drug delivery pumps and tubing, nutrition given through veins, anesthesia gases, injectable medicines, surgical sealants and stapling tools, connected hospital beds, monitoring and diagnostic equipment, and breathing support devices. It reports results in three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. Buyers include hospitals, long-term care and rehab facilities, outpatient surgery sites, physician practices, dialysis clinics, and patients treated at home. The company produces goods in more than 20 nations and sells them across the Americas, Europe, the Middle East, Africa, and Asia-Pacific.
Based on the company's 10-K filed Feb 12, 2026.
NYSE · Healthcare
SEPT Low Target
$21.00
SEPT Mid Target
$25.00
SEPT High Target
$29.00
Analyst Consensus
$25.00
Thesis
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for BAX.
Start Free Trial →Valuation Verdict
FAIR
Methods Used
P/E Forward, P/B, Analyst Consensus
Fair Value
$27.66
28
Moat Score
NONE
5/9
Piotroski Score
2.3
Altman Z-Score
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
BUYING
6 buys / 3 sells (90d)
Institutional
N/A
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Wallace Steven P. | officer | Sale | 153 | $3K | Jun 2, 2026 |
| Teaff James | officer | Sale | 321 | $6K | Jun 2, 2026 |
| Zielinski Anita A | officer | Buy | 13,426 | - | Jun 1, 2026 |
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →Revenue YoY
5.7%
3yr Revenue CAGR
3.8%
EPS Growth YoY
-47.24%
FCF Growth YoY
N/A%
Revenue Trend
ACCELERATING
SEPT Investing tracks real-time dark pool institutional trades for BAX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:42:19 | $26.34 | 1,950 | $$51K | SELL |
| 21:32:42 | $26.34 | 112,152 | $$3.0M | SELL |
| 21:28:25 | $26.34 | 8,073 | $$213K | SELL |
| 21:00:30 | $26.34 | 11,252 | $$296K | BUY |
| 21:00:30 | $26.34 | 1,794 | $$47K | BUY |
5 dark pool trades shown · $$3.6M preview volume
Real-time institutional flow, block trades, and net positioning
SEPT Investing provides real-time options flow tracking for BAX, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| PUT | $25 | Dec 18 | 37 | $$840 | 12 | SWEEP |
| PUT | $25 | Dec 18 | 37 | $$350 | 5 | SWEEP |
| PUT | $25 | Dec 18 | 37 | $$350 | 5 | SWEEP |
| PUT | $25 | Dec 18 | 37 | $$70 | 1 | SWEEP |
| PUT | $25 | Dec 18 | 37 | $$70 | 1 | SWEEP |
5 options trades shown · 0% calls
Unusual activity, GEX levels, max pain, and dealer positioning
SEPT's Trading AI has generated a free, downloadable PDF research report for BAXTER INTERNATIONAL INC (BAX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →BAXTER INTERNATIONAL INC (BAX) is at $25.74, down 2.28% (-$0.60) at the Nov 12, 2026 close.
Latest BAX news — Nov 9, 2026: Barclays keeps Underweight rating on Baxter International, lifts target to $23 · Nov 4, 2026: Baxter International revises its 2026 outlook and cuts debt
The average analyst price target for BAX is $25.00, ranging from $21 to $29, based on 10 analysts. Latest: Barclays maintains on Nov 9, 2026.
Analyst ratings for BAX: 2 Buy, 12 Hold, 1 Sell — consensus Hold.
BAX last reported on Oct 29, 2026: EPS $0.58 vs $0.52 expected — a beat of 12.0%.
Yes. BAX's dividend yield is 3.55%.
Support: $25.71, $23.62, $22.50. Resistance: $27.09, $28.38, $30.00.
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
Nov 9, 2026: Barclays keeps Underweight rating on Baxter International, lifts target to $23 · Nov 4, 2026: Baxter International revises its 2026 outlook and cuts debt · Oct 30, 2026: JP Morgan keeps Neutral rating on Baxter International, cuts price target to $25